Clinical and diagnostic evaluation of the effectiveness of treatment of optic neuropathy in patients with edematous endocrine ophthalmopathy
The aim: to conduct a clinical and diagnostic evaluation of the effectiveness of the administration of a complex of drugs in the region of hemolymphocirculation in optical neuropathy in patients with edematous form of endocrine ophthalmopathy.Materials and methods. The results of diagnosis and treat...
| Published in: | Acta Biomedica Scientifica |
|---|---|
| Main Authors: | G. V. Bratko, D. D. Dmitriev, V. I. Bratko, A. N. Trunov, V. V. Chernykh |
| Format: | Article |
| Language: | Russian |
| Published: |
Scientific Сentre for Family Health and Human Reproduction Problems
2022-03-01
|
| Subjects: | |
| Online Access: | https://www.actabiomedica.ru/jour/article/view/3294 |
Similar Items
Transorbital Endoscopic Medial Orbitotomy and Decompression of the Optic Nerve in Patients with Endocrine Ophthalmopathy Complicated by Optical Neuropathy
by: O. V. Levchenko, et al.
Published: (2020-10-01)
by: O. V. Levchenko, et al.
Published: (2020-10-01)
The role of neuron specific enolase for endocrine ophthalmopathy and the formation of optic neuropathy
by: Vladimir Vyacheslavovich Charinzev, et al.
Published: (2016-03-01)
by: Vladimir Vyacheslavovich Charinzev, et al.
Published: (2016-03-01)
Explore the Possibility of Early Clinical Diagnosis of Endocrine Ophthalmopathy Based on Eye Symptoms of Hyperthyroidism
by: V. G. Likhvantseva, et al.
Published: (2016-12-01)
by: V. G. Likhvantseva, et al.
Published: (2016-12-01)
X-RAY SEMIOTICS OF ENDOCRINE OPHTHALMOPATHY. PART 2. THE OPTIC NERVE, LACRIMAL GLAND, SUPERIOR OPHTHALMIC VEIN
by: O. Yu. Yatsenko, et al.
Published: (2017-01-01)
by: O. Yu. Yatsenko, et al.
Published: (2017-01-01)
Clinical polymorphism of endocrine ophthalmopathy
by: V. G. Likhvantseva, et al.
Published: (2014-07-01)
by: V. G. Likhvantseva, et al.
Published: (2014-07-01)
Clinical polymorphism of endocrine ophthalmopathy
by: V. G. Likhvantseva, et al.
Published: (2014-07-01)
by: V. G. Likhvantseva, et al.
Published: (2014-07-01)
MODERN APPROACHES TO THE THERAPY OF ENDOCRINE OPHTHALMOPATHY
by: Nikonova L. V., et al.
Published: (2019-03-01)
by: Nikonova L. V., et al.
Published: (2019-03-01)
Optical coherence tomography and optical coherence tomography — angiography used in endocrine ophthalmopathy
by: N. A. Gavrilova, et al.
Published: (2023-03-01)
by: N. A. Gavrilova, et al.
Published: (2023-03-01)
MINIMALLY INVASIVE METHODS OF SURGICAL TREATMENT OF ENDOCRINE OPHTHALMOPATHY
by: O. V. Levchenko, et al.
Published: (2017-07-01)
by: O. V. Levchenko, et al.
Published: (2017-07-01)
Rituximab in the treatment of Graves’ disease and endocrine ophthalmopathy. Opportunities and limitations
by: T. S. Panevin, et al.
Published: (2023-10-01)
by: T. S. Panevin, et al.
Published: (2023-10-01)
Volumetric, topographic and structural changes of orbital apex soft tissues in optic neuropathy caused by edematous exophthalmos
by: O. Yu. Yatsenko
Published: (2014-07-01)
by: O. Yu. Yatsenko
Published: (2014-07-01)
Association between polymorphic markers in candidate genes and the risk of manifestationof endocrine ophthalmopathy in patients with Graves’ disease
by: N A Petunina, et al.
Published: (2018-10-01)
by: N A Petunina, et al.
Published: (2018-10-01)
Balance decompression of orbit at endocrine ophthalmopathy. First experience
by: P. A. Kochetkov, et al.
Published: (2016-12-01)
by: P. A. Kochetkov, et al.
Published: (2016-12-01)
Selective deficits of S-cone in thyroid-associated ophthalmopathy patients without clinical signs of dysthyroid optic neuropathy
by: Haochen Jin, et al.
Published: (2022-09-01)
by: Haochen Jin, et al.
Published: (2022-09-01)
Role of cytokines, IL1-β and IL-10, in the development of endocrine ophthalmopathy in Graves’ disease
by: Yu. V. Buldygina, et al.
Published: (2021-08-01)
by: Yu. V. Buldygina, et al.
Published: (2021-08-01)
New Method of Calculating the Excess Amount of Soft Tissues of the Orbit in Patients with Endocrine Ophthalmopathy when Planning Operations
by: D. V. Davydov, et al.
Published: (2019-12-01)
by: D. V. Davydov, et al.
Published: (2019-12-01)
The significance of some growth factors in the pathogenesis of endocrine ophthalmopathy
by: Vladimir V. Charinzev, et al.
Published: (2017-07-01)
by: Vladimir V. Charinzev, et al.
Published: (2017-07-01)
A novel nomogram based on orbital MRI parameters for early prediction of dysthyroid optic neuropathy in thyroid-associated ophthalmopathy
by: Xianzhi Zhao, et al.
Published: (2025-10-01)
by: Xianzhi Zhao, et al.
Published: (2025-10-01)
Transforming growth factor β1 (TGF-β1) in patients with endocrine ophthalmopathy and Graves’ disease: A predictor of treatment efficiency
by: N. Yu. Sviridenko, et al.
Published: (2022-11-01)
by: N. Yu. Sviridenko, et al.
Published: (2022-11-01)
Orbital decompression surgery for the treatment of Graves' ophthalmopathy: comparison of different techniques and long-term results
by: Mehmet Ozgur Cubuk, et al.
Published: (2018-08-01)
by: Mehmet Ozgur Cubuk, et al.
Published: (2018-08-01)
Assessing the efficacy of various treatment regimens for patients with endocrine ophthalmopathy associated with Graves’ disease
by: Yu. V. Buldygina, et al.
Published: (2022-03-01)
by: Yu. V. Buldygina, et al.
Published: (2022-03-01)
X-ray semiotics of endocrine ophthalmopathy. Part 1. Extraocular muscles and orbital cellular tissue
by: O. Yu. Yatsenko, et al.
Published: (2016-07-01)
by: O. Yu. Yatsenko, et al.
Published: (2016-07-01)
Management of patients with endocrine ophthalmopathy and Graves' disease: results of an endocrinologist and ophthalmologist survey in Russia
Published: (2015-12-01)
Published: (2015-12-01)
Optical coherence tomography angiography in thyroid associated ophthalmopathy: a systematic review
by: Mohammad Taher Rajabi, et al.
Published: (2024-07-01)
by: Mohammad Taher Rajabi, et al.
Published: (2024-07-01)
Comparison of electroretinographic responses between two different age groups of adult Dark Agouti rats
by: Lin Fu, et al.
Published: (2015-10-01)
by: Lin Fu, et al.
Published: (2015-10-01)
Modified endoscopic transnasal orbital apex decompression in dysthyroid optic neuropathy
by: Yunhai Tu, et al.
Published: (2021-04-01)
by: Yunhai Tu, et al.
Published: (2021-04-01)
A clinical evaluation of optic neuropathy in various aetiologies
by: R Iswaria Shyamala Rani, et al.
Published: (2023-01-01)
by: R Iswaria Shyamala Rani, et al.
Published: (2023-01-01)
Radiological features of endocrine orbitopathy involving lacrimal gland
by: V. G. Likhvantseva, et al.
Published: (2014-07-01)
by: V. G. Likhvantseva, et al.
Published: (2014-07-01)
On selenium deficiency in Graves’ disease patients with autoimmune ophthalmopathy
by: Yu.V. Buldygina, et al.
Published: (2019-04-01)
by: Yu.V. Buldygina, et al.
Published: (2019-04-01)
Retinal and Choroidal Alterations in Thyroid-Associated Ophthalmopathy: A Systematic Review
by: Alexandra Magdalena Ioana, et al.
Published: (2025-02-01)
by: Alexandra Magdalena Ioana, et al.
Published: (2025-02-01)
HbA1c: an independent risk factor for dysthyroid optic neuropathy
by: Xing Wang, et al.
Published: (2023-10-01)
by: Xing Wang, et al.
Published: (2023-10-01)
Evaluation of the Effect of Proptosis on Choroidal Thickness in Graves’ Ophthalmopathy
by: Gamze Yıldırım, et al.
Published: (2020-08-01)
by: Gamze Yıldırım, et al.
Published: (2020-08-01)
Practical Guidelines Management of Graves Ophthalmopathy
by: Imam Subekti, et al.
Published: (2020-02-01)
by: Imam Subekti, et al.
Published: (2020-02-01)
Practical Guidelines Management of Graves Ophthalmopathy
by: Imam Subekti, et al.
Published: (2020-02-01)
by: Imam Subekti, et al.
Published: (2020-02-01)
Asssociation of vitamin D with autoimmune ophthalmopathy in Graves’ disease
by: Yu.V. Buldygina, et al.
Published: (2020-01-01)
by: Yu.V. Buldygina, et al.
Published: (2020-01-01)
Autophagy in graves’ ophthalmopathy
by: Yu-Qing Chen, et al.
Published: (2023-04-01)
by: Yu-Qing Chen, et al.
Published: (2023-04-01)
Evaluation of retinal nerve fiber layer thickness profile in thyroid ophthalmopathy without optic nerve dysfunction
by: Kumari Mugdha, et al.
Published: (2016-12-01)
by: Kumari Mugdha, et al.
Published: (2016-12-01)
Key indicators for guiding tocilizumab therapy to prevent orbital decompression surgery in hormone-resistant dysthyroid optic neuropathy
by: Wenjun Shu, et al.
Published: (2025-05-01)
by: Wenjun Shu, et al.
Published: (2025-05-01)
Altered spontaneous brain activity patterns in dysthyroid optic neuropathy: a resting-state fMRI study
by: Yi-Ping Jiang, et al.
Published: (2021-06-01)
by: Yi-Ping Jiang, et al.
Published: (2021-06-01)
Diagnostic dilemma: Leber's hereditary optic neuropathy in a 70-year-Old woman
by: Alexandra Pietraszkiewicz, et al.
Published: (2024-12-01)
by: Alexandra Pietraszkiewicz, et al.
Published: (2024-12-01)
Similar Items
-
Transorbital Endoscopic Medial Orbitotomy and Decompression of the Optic Nerve in Patients with Endocrine Ophthalmopathy Complicated by Optical Neuropathy
by: O. V. Levchenko, et al.
Published: (2020-10-01) -
The role of neuron specific enolase for endocrine ophthalmopathy and the formation of optic neuropathy
by: Vladimir Vyacheslavovich Charinzev, et al.
Published: (2016-03-01) -
Explore the Possibility of Early Clinical Diagnosis of Endocrine Ophthalmopathy Based on Eye Symptoms of Hyperthyroidism
by: V. G. Likhvantseva, et al.
Published: (2016-12-01) -
X-RAY SEMIOTICS OF ENDOCRINE OPHTHALMOPATHY. PART 2. THE OPTIC NERVE, LACRIMAL GLAND, SUPERIOR OPHTHALMIC VEIN
by: O. Yu. Yatsenko, et al.
Published: (2017-01-01) -
Clinical polymorphism of endocrine ophthalmopathy
by: V. G. Likhvantseva, et al.
Published: (2014-07-01)
